We are live on
!
Find out more
SRC
Shufro Rose & Co Portfolio holdings
AUM
$1.47B
1-Year Est. Return
19.38%
This Fund
S&P 500
This Quarter
Est. Return
+19.29%
1 Year Est. Return
+19.38%
3 Year Est. Return
+47.49%
5 Year Est. Return
+55.37%
10 Year Est. Return
+200.77%
AUM
$1.01B
AUM Growth
+$175M
(+21%)
Cap. Flow
+$27.4M
Cap. Flow
% of AUM
2.7%
Top 10 Holdings %
Top 10 Hldgs %
37.11%
Holding
314
New
21
Increased
41
Reduced
132
Closed
27
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Short Maturity Bond ETF
NEAR
|
+$61.5M |
| 2 |
iShares MSCI USA Min Vol Factor ETF
USMV
|
+$28.9M |
| 3 |
AbbVie
ABBV
|
+$8.08M |
| 4 |
iShares MSCI USA Quality Factor ETF
QUAL
|
+$6.34M |
| 5 |
JPMorgan Chase
JPM
|
+$4.01M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco S&P 500 Equal Weight ETF
RSP
|
+$19.1M |
| 2 |
AGN
Allergan plc
AGN
|
+$18.7M |
| 3 |
BSCK
Invesco BulletShares 2020 Corporate Bond ETF
BSCK
|
+$8.42M |
| 4 |
Amgen
AMGN
|
+$4.08M |
| 5 |
Howmet Aerospace
HWM
|
+$4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.12% |
| 2 | Healthcare | 12.27% |
| 3 | Financials | 11.87% |
| 4 | Consumer Discretionary | 11.2% |
| 5 | Industrials | 6.56% |
Similar funds
SVWAG
KRSITF
CWM
AAIM
SWA
VCP
PWMAG
ACM
Shufro Rose & Co's Q2 2020 Portfolio in Review
As of Q2 2020, Shufro Rose & Co held 314 positions worth $1.01B, up 21% from $839M the previous quarter. Its ten largest holdings account for 37% of the portfolio.
Shufro Rose & Co's Q2 2020 filing shows 21 new, 41 increased, 132 reduced and 27 closed positions. Its largest new stake was iShares Short Maturity Bond ETF: 1,245,054 shares worth $62.3M. The largest sale was Invesco S&P 500 Equal Weight ETF, an estimated $19.1M.
By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 23% a quarter earlier, followed by Healthcare and Financials.
- Shufro Rose & Co's largest Q2 2020 buy was iShares Short Maturity Bond ETF: 1,245,054 shares worth $62.3M.
- Shufro Rose & Co added most to iShares MSCI USA Min Vol Factor ETF in Q2 2020, an estimated $28.9M increase.
- Shufro Rose & Co's biggest Q2 2020 reduction was Invesco S&P 500 Equal Weight ETF, cutting an estimated $19.1M.
- Shufro Rose & Co fully exited Allergan plc in Q2 2020, selling an estimated $18.7M.
- Shufro Rose & Co's ten largest holdings make up 37% of its $1.01B portfolio in Q2 2020.
- Shufro Rose & Co opened 21 new positions and closed 27 in Q2 2020.
- Shufro Rose & Co's portfolio value rose 21% quarter-over-quarter to $1.01B.
Based on Shufro Rose & Co's 13F filing for Q2 2020, filed 6 Aug 2020.